241 related articles for article (PubMed ID: 9349232)
1. Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus.
Herbst H; Samol J; Foss HD; Raff T; Niedobitek G
J Pathol; 1997 Jul; 182(3):299-306. PubMed ID: 9349232
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic modulation of Hodgkin and Reed-Sternberg cells by Epstein-Barr virus.
Herbst H; Raff T; Stein H
J Pathol; 1996 May; 179(1):54-9. PubMed ID: 8691346
[TBL] [Abstract][Full Text] [Related]
3. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
[TBL] [Abstract][Full Text] [Related]
4. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
[TBL] [Abstract][Full Text] [Related]
5. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease.
Beck A; Päzolt D; Grabenbauer GG; Nicholls JM; Herbst H; Young LS; Niedobitek G
J Pathol; 2001 Jun; 194(2):145-51. PubMed ID: 11400141
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of major histocompatibility complex class I and LMP1 in Epstein-Barr virus-positive Hodgkin's lymphoma in a pediatric age group.
Aybar A; Krause JR
Microsc Res Tech; 2005 Nov; 68(3-4):247-9. PubMed ID: 16276512
[TBL] [Abstract][Full Text] [Related]
7. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Martinez RL; Alkan S
Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
[TBL] [Abstract][Full Text] [Related]
9. Expression of the tumour necrosis factor receptor-associated factors 1 and 2 in Hodgkin's disease.
Murray PG; Flavell JR; Baumforth KR; Toomey SM; Lowe D; Crocker J; Ambinder RF; Young LS
J Pathol; 2001 Jun; 194(2):158-64. PubMed ID: 11400143
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus in Hodgkin's disease.
Herbst H
Semin Cancer Biol; 1996 Aug; 7(4):183-9. PubMed ID: 8946602
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma.
Gulley ML; Glaser SL; Craig FE; Borowitz M; Mann RB; Shema SJ; Ambinder RF
Am J Clin Pathol; 2002 Feb; 117(2):259-67. PubMed ID: 11863222
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Separate events in the pathogenesis of Hodgkin's disease?
Khan G; Gupta RK; Coates PJ; Slavin G
Am J Pathol; 1993 Nov; 143(5):1270-4. PubMed ID: 8238244
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystander.
Oudejans JJ; Jiwa NM; Meijer CJ
J Pathol; 1997 Apr; 181(4):353-6. PubMed ID: 9196428
[TBL] [Abstract][Full Text] [Related]
14. IgH and TcR-gamma gene rearrangements identified in Hodgkin's disease by PCR demonstrate lack of correlation between genotype, phenotype, and Epstein-Barr virus status.
Al Saati T; Galoin S; Gravel S; Lamant L; Roda D; Chittal SM; Delsol G
J Pathol; 1997 Apr; 181(4):387-93. PubMed ID: 9196435
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus in Reed-Sternberg-like cells in non-Hodgkin's lymphomas.
Khan G; Norton AJ; Slavin G
J Pathol; 1993 Jan; 169(1):9-14. PubMed ID: 8381864
[TBL] [Abstract][Full Text] [Related]
16. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease.
Dukers DF; Jaspars LH; Vos W; Oudejans JJ; Hayes D; Cillessen S; Middeldorp JM; Meijer CJ
J Pathol; 2000 Feb; 190(2):143-9. PubMed ID: 10657011
[TBL] [Abstract][Full Text] [Related]
17. Expression of bcl-2 protein and Epstein-Barr virus latent membrane protein in Hodgkin's disease.
Kordek R; Biernat W; Kupnicka D; Woźniak L
Pol J Pathol; 1994; 45(4):279-81. PubMed ID: 7697330
[TBL] [Abstract][Full Text] [Related]
18. Human herpesvirus-6 (HHV-6) in Hodgkin's disease: cellular expression of viral antigens as compared to oncogenes met and fes, tumor suppressor gene product p53, and interleukins 2 and 6.
Krueger GR; Guenther A; Knuefermann R; Kluppelberg U; Luka J; Pearson GR; Ablashi DV; Juecker M; Tesch H
In Vivo; 1994; 8(4):501-16. PubMed ID: 7893977
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus expression in Hodgkin's disease in Jordan.
Almasri NM; Khalidi HS
Saudi Med J; 2004 Jun; 25(6):770-5. PubMed ID: 15195209
[TBL] [Abstract][Full Text] [Related]
20. Expression of heat shock protein 70 (HSP70) and EBV latent membrane protein 1 (LMP1) in Reed-Sternberg cells of Hodgkin's disease.
Takahashi H; Fujita S; Shibata Y; Tsuda N; Okabe H
Anal Cell Pathol; 1996 Nov; 12(2):71-83. PubMed ID: 8986292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
